A 3-year-old unvaccinated child from rural India presents with acute meningitis. CSF culture grows Haemophilus influenzae. Regarding the laboratory identification and antibiotic susceptibility of this organism, all of the following are correct EXCEPT:

Explanation

## Laboratory Identification and Antibiotic Susceptibility of H. influenzae ### Correct Statements (Options 0, 1, 2) **Key Point:** H. influenzae is a fastidious gram-negative coccobacillus that requires X factor (hemin/iron) and V factor (NAD) for growth. These factors are present in chocolate agar (where blood is heated, releasing these factors) but NOT in regular blood agar, making chocolate agar the medium of choice for isolation. **High-Yield:** Oxidase positivity is a rapid screening test for H. influenzae and other gram-negative organisms such as Neisseria and Pseudomonas. This is one of the first tests performed on gram-negative isolates. **Clinical Pearl:** Beta-lactamase production is the most common mechanism of ampicillin resistance in H. influenzae, particularly in India where prevalence is high (20–40%). Beta-lactamase-producing strains are resistant to ampicillin but remain susceptible to cephalosporins (due to different beta-lactamase substrate specificity). ### The Incorrect Statement (Option 3) **Key Point:** H. influenzae is **NOT intrinsically resistant to vancomycin**. In fact, vancomycin is highly effective against H. influenzae and is a standard agent for empiric meningitis coverage in patients with beta-lactam allergy or when ampicillin-resistant H. influenzae (ARHI) is suspected. **Warning:** This is a critical clinical misconception. Vancomycin penetrates the CSF adequately and achieves bactericidal concentrations in meningitis. It is NOT contraindicated — it is actually a preferred agent when beta-lactam resistance is present. **Clinical Pearl:** In India, empiric meningitis coverage in unvaccinated children typically includes ceftriaxone (or cefotaxime) + vancomycin + acyclovir (for HSV coverage). Vancomycin is added specifically because of the high prevalence of beta-lactamase-producing H. influenzae. ### Treatment Algorithm for H. influenzae Meningitis ```mermaid flowchart TD A[H. influenzae meningitis suspected]:::outcome --> B{Beta-lactamase test result}:::decision B -->|Negative| C[Ceftriaxone or cefotaxime]:::action B -->|Positive| D[Ceftriaxone + Vancomycin]:::action B -->|Unknown/Pending| E[Empiric: Ceftriaxone + Vancomycin]:::action C --> F[Vancomycin NOT needed]:::outcome D --> G[Vancomycin IS effective]:::outcome E --> G ``` ### Antibiotic Susceptibility Profile | Antibiotic | H. influenzae Susceptibility | Notes | | --- | --- | --- | | Ampicillin | Variable (ARHI common in India) | Beta-lactamase-mediated resistance | | Cephalosporins (3rd gen) | Susceptible | Preferred for meningitis | | Vancomycin | Susceptible | Effective in meningitis, NOT contraindicated | | Fluoroquinolones | Susceptible | Alternative for respiratory infections | | Trimethoprim-sulfamethoxazole | Variable | Less reliable | **High-Yield:** Vancomycin is a glycopeptide antibiotic that is highly effective against H. influenzae and achieves adequate CSF penetration in meningitis (especially with inflamed meninges). It is a cornerstone of empiric meningitis therapy.